These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20090459)

  • 21. High-grade mucoepidermoid carcinoma of the accessory parotid gland with distant metastases identified by 18F-FDG PET-CT.
    Gomes M; Pepe G; Bomanji J; Al-Salihi O; Du Y; Gacinovic S; Ell P
    Pediatr Blood Cancer; 2008 Feb; 50(2):395-7. PubMed ID: 16977607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recoverin-associated retinopathy secondary to Warthin tumor of parotid gland.
    Machida S; Ohguro H; Ishida K; Suzuki M; Kawagishi K
    Doc Ophthalmol; 2014 Oct; 129(2):123-8. PubMed ID: 25149652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. F-18 FDG PET/CT findings of dedifferentiated acinic cell carcinoma.
    Hyun O J; Yoo IeR; Jung CK; Hoon Kim S; Chung SK
    Clin Nucl Med; 2010 Jun; 35(6):473-4. PubMed ID: 20479609
    [No Abstract]   [Full Text] [Related]  

  • 24. Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer.
    Bitar R; Martiniova L; Bell D; Ravizzini G
    Clin Nucl Med; 2020 Apr; 45(4):e208-e210. PubMed ID: 31977491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warthin's tumor and the I-123 scan.
    Moinuddin M; Rockett JF
    J Nucl Med; 1980 Sep; 21(9):898-0. PubMed ID: 7411231
    [No Abstract]   [Full Text] [Related]  

  • 26. Adenolymphoma of the parotid gland.
    McGurk FM; Main JH; Orr JA
    Br J Surg; 1970 May; 57(5):321-5. PubMed ID: 5427875
    [No Abstract]   [Full Text] [Related]  

  • 27. [Radiotherapy for an adenolymphoma of the parotid gland (Warthin tumor)].
    Stallmann C; Vacha P; Vesely H; Richter E; Feyerabend T
    Strahlenther Onkol; 2001 May; 177(5):247-51. PubMed ID: 11398610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual Vignette.
    Rafii DC; Greif EF; Finestone H; Karam J
    Endocr Pract; 2017 Jul; 23(7):891. PubMed ID: 28095049
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of scintigraphy in the diagnosis of papillary cystadenolymphoma. Apropos of 3 cases].
    Lejuste P; Piette E; Reychler H
    Acta Stomatol Belg; 1984 Sep; 81(2):107-17. PubMed ID: 6093485
    [No Abstract]   [Full Text] [Related]  

  • 30. Warthin tumor: a potential source of diagnostic error.
    Colella G; Tozzi U; Pagliarulo V; Bove P
    J Craniofac Surg; 2010 Nov; 21(6):1978-81. PubMed ID: 21119475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral papillary cystadenoma lymphomatosum of the parotid gland without accumulation of technetium 99m pertechnetate: report of a case and review of the literature.
    Yoshimura Y; Nohtomi M
    J Oral Maxillofac Surg; 1991 Apr; 49(4):401-4. PubMed ID: 1848611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bilateral Warthin's tumor of the parotid gland].
    Przewoźny T; Stankiewicz C; Narozny W; Kuczkowski J
    Otolaryngol Pol; 2004; 58(6):1203-9. PubMed ID: 15732851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal cell adenoma and myoepithelioma of the parotid gland: patterns of enhancement at two-phase CT in comparison with Warthin tumor.
    Lee JY; Kim HJ; Kim YK; Cha J; Kim ST
    Diagn Interv Radiol; 2019 Jul; 25(4):285-290. PubMed ID: 31120425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor pathology of the salivary glands: comparison and value of various radiologic study methods].
    Vacher C; Favre-Dauvergne E; Bertrand JC; Guilbert F
    Rev Stomatol Chir Maxillofac; 1994; 95(2):137-9. PubMed ID: 8036405
    [No Abstract]   [Full Text] [Related]  

  • 36. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
    Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland.
    Basu S; Mahne A; Iruvuri S; Alavi A
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):309-14. PubMed ID: 17324340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinomycosis imitating parotid cancer with metastatic lymph nodes in FDG PET/CT.
    Mok GS; Choi FP; Chu WC
    Clin Nucl Med; 2011 Apr; 36(4):309-10. PubMed ID: 21368609
    [No Abstract]   [Full Text] [Related]  

  • 39. False-positive FDG PET/CT uptake in Warthin tumor in head and neck oncological patients confirmed by a fine needle aspiration.
    Klijanienko J; Petras S; De Bosschere L; Paulmier B; Le Tourneau C; Rodriguez J
    Diagn Cytopathol; 2012 Mar; 40(3):282-4. PubMed ID: 21591273
    [No Abstract]   [Full Text] [Related]  

  • 40. Sclerosing polycystic adenosis of the parotid gland presenting with a Warthin tumor.
    Tokyol C; Aktepe F; Hastürk GS; Yıldız H; Miman MC
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):288-92. PubMed ID: 22991990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.